top of page

Investigating Potential Immunotherapies: Advancements in T-Cell Therapies for Cancer

Antibody. 3D. Virus, antibodies and t-cells

The fight against cancer is a relentless pursuit, with scientists and medical researchers continuously seeking new and effective treatments. Among the most promising avenues are T-cell therapies, which harness the power of the immune system to eliminate cancerous cells. However, while T-cell therapies have shown remarkable success in some cases, their efficacy against solid tumors has been notably challenging. The key to overcoming this challenge lies in understanding and manipulating the tumor microenvironment.

Solid tumors present a unique obstacle; their microenvironment can significantly influence the effectiveness of T-cell and other immunotherapies. Traditional 2D cell models fail to replicate the complex interactions within this microenvironment, leading to a gap in our understanding and limiting the development of effective treatments. Enter 3D cell models—an innovative approach that brings us closer to mimicking the actual conditions within a human body.

3D Cell Models: A Game Changer in Cancer Research

3D cell models, such as spheroids, offer a more accurate representation of the tumor microenvironment. These models allow researchers to observe how cancer cells interact with each other and with immune cells in a more realistic setting. By employing 3D models, scientists can gain a better understanding of how specific therapies might perform in patients, paving the way for more effective treatments.

Automation plays a crucial role in this advanced research. By integrating automated systems, researchers can significantly increase the throughput of their assays while reducing manual effort and enhancing reliability. One exemplary workflow involves the use of the BioAssemblyBot® 400 Automated Bioprinting Solution to plate cancer cells, allowing them to grow into spheroids, followed by the addition of activated T-cells. This setup closely mimics the conditions in which T-cells must operate to infiltrate and attack tumors.

The Workflow in Action

In this innovative workflow, several advanced technologies are utilized to monitor and analyze the interaction between T-cells and cancer spheroids:

  1. BioAssemblyBot® 400 Automated Bioprinting Solution: This automated system plates cancer cells and enables them to grow into spheroids. It also facilitates the addition of activated T-cells, setting the stage for further analysis.

  2. ImageXpress Confocal High-Content Imaging System: This high-content imaging system monitors spheroid growth and evaluates the degree of T-cell infiltration. The ability to visually track these interactions in real-time provides valuable insights into the efficacy of the T-cell therapy.

  3. SpectraMax® iD5 Multi-Mode Microplate Reader: This device is used to measure cytokine levels, which serve as markers of the immune response. By evaluating cytokine levels, researchers can determine the intensity of the immune reaction against the tumor cells.

The Future of Cancer Treatment

The combination of 3D cell models and automation represents a significant leap forward in cancer research. These advancements not only enhance our understanding of how T-cell therapies interact with solid tumors but also expedite the development of more effective treatments. As researchers continue to refine these techniques, the potential for breakthrough therapies increases, offering hope for more effective cancer treatments in the future.

Want to Perform a Similar Workflow in Your Lab?

If you are interested in implementing a similar workflow in your laboratory, contact our team today to learn more about the BioAssemblyBot® 400, ImageXpress Confocal, and SpectraMax® iD5 systems. Unlock the power of 3D imaging and machine learning to advance your research and contribute to the fight against cancer.


T-cell therapies hold great promise for the future of cancer treatment, particularly in their potential to overcome the challenges posed by solid tumors. Through the use of 3D cell models and automated technologies, researchers are making significant strides in understanding and enhancing these therapies. As we continue to innovate and explore new methodologies, the goal of finding a cure for cancer becomes ever more attainable.

For more detailed information and to speak with our team about how you can adopt these cutting-edge techniques in your research, visit our application note on monitoring T-cell invasions using a 3D spheroid model. Together, we can push the boundaries of cancer treatment and move closer to a world free of this devastating disease.


Commenting has been turned off.
bottom of page